Health Care and Treatment
→
- 01 Jul 2020
- Working Paper Summaries
Social Interactions in Pandemics: Fear, Altruism, and Reciprocity
An analysis of 89 cities worldwide shows that mobility responds to infection risk, altruism, and reciprocity. Correcting the SIR model to account for this behavior shows that a balanced approach involving stringency measures, in respect of human dignity, and responsible social preferences mitigates the pandemic health and economic costs.
- 15 Jun 2020
- Research & Ideas
A Mass Crisis Can Overwhelm Health Care. Liberia Found a Solution.
Liberia trains community workers to help medical professionals on the front lines of disease control, says Brian Trelstad. Could the model work elsewhere? Open for comment; Comment(s) posted.
- 11 Jun 2020
- Working Paper Summaries
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
Without a vaccine for COVID-19, the medical community has turned to a century-old therapy. This paper discusses a market design approach for expanding the collection and distribution of convalescent plasma.
- 11 Jun 2020
- COVID-19
Are Digital Organizations Better at Overcoming COVID?
Experts from Harvard Business School's Digital Initiative discuss how technology is helping leading companies gain an edge during the coronavirus pandemic. Open for comment; Comment(s) posted.
- 09 Jun 2020
- Cold Call Podcast
In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?
How should the vaccine alliance Gavi respond to the worldwide need for a cure for the COVID-19 pandemic? Tarun Khanna discusses his case study. Open for comment; Comment(s) posted.
- 01 Jun 2020
- Working Paper Summaries
Spreading the Health: Americans' Estimated and Ideal Distributions of Death and Health(care)
Across varying political ideologies and income levels, Americans both underestimate the current extent of inequality of mortality and healthcare, and prefer each to be more equally distributed.
- 01 Jun 2020
- Working Paper Summaries
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
Retail pharmacy data illustrates it can be misleading to use list prices instead of net prices to understand pharmaceutical prices. Analysts and economists working in public policy should be extremely cautious in drawing policy conclusions based on list prices alone.
- 31 May 2020
- Working Paper Summaries
Demystifying the Math of the Coronavirus
This paper provides a conceptual model for the progression of COVID-19 that is somewhat imprecise but that’s very simple and easy to understand. By relying on this description, one can obtain a rough estimate of the impact of various social distancing measures on the rate of growth of new infections.
- 27 May 2020
- COVID-19
What South Korea Teaches the World About Fighting COVID
South Korea initially had the largest number of Coronavirus infections outside of China, but new cases have decreased sharply. What is the country doing right? asks Doug Chung. Open for comment; Comment(s) posted.
- 22 May 2020
- COVID-19
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus pandemic might lead to major changes in patient care, physician compensation, and regulation. Experts from Harvard Business School's Health Care Initiative share their predictions. Open for comment; Comment(s) posted.
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
A public insurance option could use its scale to hold prices down, but only if the approach avoids the financing gimmicks that are undermining Medicare, say Regina E. Herzlinger and James Wallace. Open for comment; Comment(s) posted.
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
In Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Ariel Dora Stern asks whether "value-based pricing" should become the standard elsewhere. Open for comment; Comment(s) posted.
- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
Nine working papers by Srikant M. Datar and colleagues explore technologies pioneered during the late 20th century that US internists say have greatly improved patient care.
- 31 Jul 2019
- Research & Ideas
Distressed Employees? Try Resilience Training
Depressed employees are up to five times more likely to experience work-related problems than employees with chronic physical illnesses. So why aren't employers helping them? asks Ashley Whillans. Open for comment; Comment(s) posted.
- 02 Jul 2019
- Working Paper Summaries
Risk-Mitigating Technologies: The Case of Radiation Diagnostic Devices
Changes in risk perception, driven by extensive media coverage of accidents, for example, can be an important driver of innovation and shape the direction of technological progress. Large firms may play an important role in the development and commercialization of risk-mitigating technologies, with important implications for the dynamics of competitive advantage and market structure.
- 17 Jun 2019
- Research & Ideas
What Hospitals Must Learn to Compete
3QUESTIONS Why is it so difficult for American health care providers to compete for customers? Raffaella Sadun and Leemore Dafny discuss why health care needs a business strategy. Open for comment; Comment(s) posted.
- 06 May 2019
- Research & Ideas
Consumers Blame Business for Global Health Problems. Can Business Become the Solution?
Millions of people have been harmed by cigarettes, defective merchandise, pollution, addiction and other business by-products. now, pioneering companies are exploring healthier ways to operate, say Amy C. Edmondson and Dr. Howard K. Koh. Open for comment; Comment(s) posted.
- 21 Mar 2019
- Working Paper Summaries
Advancing Computational Biology and Bioinformatics Research Through Open Innovation Competitions
Crowdsourcing is a way for many individuals to address a common problem. This paper describes the design and outcomes of three crowdsourcing contests focused on algorithms for 1) clustering antibody sequences, 2) imputing gene expression measurements, and 3) performing fast queries on a particular dataset. Innovation through contests greatly improved the solutions available.
- 28 Feb 2019
- Cold Call Podcast
Pursuing Precision Medicine at Intermountain Healthcare
What happens when Intermountain Healthcare invests resources in an innovative precision medicine unit to provide life-extending, genetically targeted therapies to late-stage cancer patients? Professors Richard Hamermesh and Kathy Giusti discuss the case and its connections to their work with the Kraft Precision Medicine Accelerator. Open for comment; Comment(s) posted.
SmileDirect Looks Beyond Direct-to-Consumer Marketing
PODCAST: Teledentistry company SmileDirectClub is butting up against the limits of direct-to-consumer marketing. Len Schlesinger discusses his recent case study with Matt Higgins. Open for comment; Comment(s) posted.